The Global Lactulose Concentrate Market was valued at USD 168 million in 2024 and is projected to reach USD 180 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 2.7% during the forecast period (2024–2032). This growth is being driven by rising global incidences of chronic liver disease and gastrointestinal disorders, aging populations requiring sustained digestive care, and the accelerating adoption of food-grade lactulose in functional foods and prebiotic formulations.

As the healthcare and wellness industries shift toward preventative and targeted nutritional therapies, the spotlight is on the key manufacturers who are driving innovation, ensuring supply chain reliability, and pioneering new applications. In this blog, we profile the Top 10 Companies in the Lactulose Concentrate Industry—a mix of pharmaceutical giants, specialized nutrition players, and ingredient specialists shaping the future of digestive health.

---

🔟 1. Fresenius Kabi AG

Headquarters: Bad Homburg, Germany
Key Offering: Pharmaceutical-Grade Lactulose Concentrate, Clinical Nutrition Solutions

Fresenius Kabi is a global leader in clinical nutrition and pharmaceutical-grade lactulose supply. The company’s lactulose concentrate is a critical component in its portfolio for managing hepatic encephalopathy and chronic constipation, distributed through extensive hospital and pharmacy networks worldwide.

Strategic Initiatives:

• Global expansion of production capacity, including a significant €30 million investment in Indian manufacturing facilities
• Strong focus on vertical integration and supply chain security for active pharmaceutical ingredients (APIs)
• Continuous R&D for high-purity formulations to meet stringent global pharmacopeia standards

Download FREE Sample Report: Lactulose Concentrate Market – View in Detailed Research Report

---

9️⃣ 2. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: Lactulose Solutions (e.g., Constulose, Kristalose), Medical Nutrition Products

Abbott is a powerhouse in medical nutrition and branded pharmaceuticals, holding a significant share of the prescription lactulose market in North America. Its focus on digestive health within its broad nutrition segment makes it a dominant and influential player.

Strategic Initiatives:

• Strategic acquisitions to strengthen its position in the digestive health API and formulation space
• Investment in patient adherence programs and digital health tools for chronic condition management
• Strong branding and formulary placement within U.S. and European healthcare systems

---

8️⃣ 3. Illovo Sugar Africa (Pty) Ltd

Headquarters: Umhlanga, South Africa
Key Offering: Pharmaceutical- and Food-Grade Lactulose, Lactulose Syrup

Illovo Sugar, part of the Associated British Foods group, is a major producer of lactulose derived from its sugar operations. It serves both pharmaceutical and growing food ingredient markets, leveraging its cost-competitive position in raw material sourcing.

Strategic Initiatives:

• Leveraging integrated sugar operations for reliable, cost-effective feedstock
• Focus on expanding food-grade lactulose applications in functional foods, particularly in growing African markets
• Recorded 12% volume growth in its pharmaceutical-grade segment in 2023

---

7️⃣ 4. Morinaga Milk Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High-Purity Lactulose, Prebiotic Ingredients, Dairy-based Ingredients

Morinaga is a premier player in the Asia-Pacific lactulose market, known for its high-purity standards and innovation in prebiotic applications. Its expertise bridges pharmaceuticals and advanced food science, catering to Japan’s and Southeast Asia’s discerning markets.

Strategic Initiatives:

• Specialization in ultra-high-purity lactulose for sensitive pharmaceutical applications and infant nutrition
• R&D focus on synergistic prebiotic blends combining lactulose with other functional fibers
• Expansion of its B2B ingredient business across Southeast Asia

Download FREE Sample Report: Lactulose Concentrate Market – View in Detailed Research Report

---

6️⃣ 5. Biofac A/S

Headquarters: Kalundborg, Denmark
Key Offering: Pharmaceutical Lactulose, Contract Manufacturing of APIs

Biofac is a key European contract manufacturer and supplier of pharmaceutical-grade lactulose. The company’s strength lies in its rigorous quality control, regulatory expertise, and flexible manufacturing setups serving both large pharma and smaller specialty firms.

Strategic Initiatives:

• Investment in advanced purification technologies and continuous manufacturing processes
• Implementation of blockchain-based traceability systems for full supply chain transparency
• Strong client focus on customized lactulose formulations and reliable API supply

---

5️⃣ 6. Solactis Group

Headquarters: Carquefou, France
Key Offering: SOLACTIS® Lactulose (Food & Pharma Grades), Specialty Prebiotics

Solactis is a specialized producer focused exclusively on lactulose and its derivatives. It has carved a strong niche by offering tailored lactulose solutions for both the pharmaceutical industry and the fast-growing functional food and supplement sector.

Strategic Initiatives:

• Significant investment in cold-chain and specialized logistics for temperature-sensitive lactulose products
• Active development of combination products, such as lactulose with probiotics, for enhanced gut health benefits
• Strategic focus on educating brand owners about lactulose’s prebiotic efficacy

---

4️⃣ 7. Jiangxi Haiersi Pharmaceutical Co., Ltd.

Headquarters: Nanchang, Jiangxi, China
Key Offering: Lactulose Concentrate (Pharma Grade), Lactulose Oral Solution

Jiangxi Haiersi is a leading Chinese manufacturer of lactulose, primarily serving the domestic pharmaceutical market, which is one of the world’s largest. The company benefits from the massive local demand for hepatic and digestive health products.

Strategic Initiatives:

• Scaling production capacity to meet surging domestic demand, with expansions between 15-20% in recent years
• Focus on cost-optimized manufacturing to maintain competitiveness in price-sensitive markets
• Navigating China’s evolving pharmaceutical regulations to ensure compliance and market access

---

3️⃣ 8. Dandong Kangfu Pharmaceutical Co., Ltd.

Headquarters: Dandong, Liaoning, China
Key Offering: Lactulose Concentrate, Lactulose Crystals, Lactulose Oral Liquid

Dandong Kangfu is another major Chinese player with substantial lactulose production capacity. It competes effectively in both the domestic market and in exports, particularly to other Asian and emerging economies.

Strategic Initiatives:

• Investment in crystallization technology to offer diverse lactulose forms (liquid, concentrate, crystals)
• Building export networks to leverage China’s cost advantages in API manufacturing
• Focus on consistent quality to meet the standards of international pharmaceutical customers

---

2️⃣ 9. Mankind Pharma Ltd.

Headquarters: New Delhi, India
Key Offering: Branded Lactulose Formulations (e.g., Lacson), Generic Pharmaceuticals

Mankind Pharma is a dominant force in the Indian pharmaceutical market, with a strong portfolio in gastroenterology. Its branded lactulose products command significant market share in India, a country accounting for roughly 20% of global consumption.

Strategic Initiatives:

• Deep penetration of branded generics in India’s vast retail pharmacy and hospital channels
• Aggressive marketing and high-volume, low-margin strategy suited to the price-sensitive Indian market
• Expanding its API sourcing and manufacturing to secure supply for its fast-growing branded business

---

1️⃣ 10. Gujarat Cosmos Products Ltd.

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Lactulose Powder and Syrup, Food Ingredients, Sugar Derivatives

Gujarat Cosmos is a significant Indian manufacturer of lactulose and other sugar-based derivatives. It supplies both pharmaceutical companies and the food industry, capitalizing on India’s strategic position as a low-cost manufacturing hub.

Strategic Initiatives:

• Leveraging India’s large-scale sugar industry for feedstock security and cost efficiency
• Expanding food-grade lactulose production to tap into the global prebiotic ingredients trend
• Focus on export markets to diversify beyond the competitive domestic pharmaceutical sector

Read Full Report: Lactulose Concentrate Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Lactulose Concentrate Is Diversified and Innovation-Led

The lactulose concentrate market is experiencing a strategic evolution. While pharmaceutical applications for hepatic encephalopathy and chronic constipation continue to anchor demand, the industry is investing in new application pathways, process optimizations, and supply chain resilience to drive future growth.

📈 Key Trends Shaping the Market:

• Rapid growth of the food-grade segment, with applications in prebiotic fibers, functional foods, and infant nutrition
• Regulatory harmonization and increased quality standards in key emerging markets like China and India
• Technological advancements in production and purification to enhance yield, purity, and cost-effectiveness
• Strategic consolidation and partnerships as major players secure API supply chains and expand geographic footprint

Read Full Report: Lactulose Concentrate Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic ingredient—they’re enabling the broader transition toward proactive digestive and metabolic health worldwide.